AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML
Publication
, Conference
Lundberg, S; Chau, M; Erba, HP; Dressel, AL; Acton, G; Capizzi, RL; Baer, MR
Published in: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
June 1, 2009
Duke Scholars
Published In
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
EISSN
1592-8721
ISSN
0390-6078
Publication Date
June 1, 2009
Volume
94
Start / End Page
338 / 339
Location
Berlin, GERMANY
Publisher
FERRATA STORTI FOUNDATION
Conference Name
14th Annual Meeting of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lundberg, S., Chau, M., Erba, H. P., Dressel, A. L., Acton, G., Capizzi, R. L., & Baer, M. R. (2009). AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (Vol. 94, pp. 338–339). Berlin, GERMANY: FERRATA STORTI FOUNDATION.
Lundberg, S., M. Chau, H. P. Erba, A. L. Dressel, G. Acton, R. L. Capizzi, and M. R. Baer. “AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML.” In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 94:338–39. FERRATA STORTI FOUNDATION, 2009.
Lundberg S, Chau M, Erba HP, Dressel AL, Acton G, Capizzi RL, et al. AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. FERRATA STORTI FOUNDATION; 2009. p. 338–9.
Lundberg, S., et al. “AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML.” HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol. 94, FERRATA STORTI FOUNDATION, 2009, pp. 338–39.
Lundberg S, Chau M, Erba HP, Dressel AL, Acton G, Capizzi RL, Baer MR. AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. FERRATA STORTI FOUNDATION; 2009. p. 338–339.
Published In
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
EISSN
1592-8721
ISSN
0390-6078
Publication Date
June 1, 2009
Volume
94
Start / End Page
338 / 339
Location
Berlin, GERMANY
Publisher
FERRATA STORTI FOUNDATION
Conference Name
14th Annual Meeting of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology